Although we did not assess molecular pathways underling such alterations and the impact of IGF1-R on these genomic findings, Worthington et al. reported that IGF1-dependent signaling and proliferation were enhanced in ErbB2-overexpressing cells and with increased invasiveness and anchorage-independent colony formation in breast cancer [16]. Here, ERBB2 is linked to breast carcinoma.